FDA Inspection 1215824 — Sanofi-Aventis Deutschland GmbH
The FDA completed an inspection of Sanofi-Aventis Deutschland GmbH on Mar 25, 2022 in Frankfurt Am Main. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Frankfurt Am Main (Germany)
Additional details
Mutual Recognition Agreement (MRA)